Category: Biosimilars
Biosimilars market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
The 2025-2030 World Outlook for Biosimilars and Related Biologics This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Biosimilars
The 2025-2030 World Outlook for Biosimilars This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb) This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
The 2025-2030 World Outlook for Biosimilar Drugs This study covers the world outlook for biosimilar drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars
The 2025-2030 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars This study covers the world outlook for recombinant non-glycosylated protein biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilars
The 2025-2030 World Outlook for Generic Biosimilars This study covers the world outlook for generic biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Immunology Treatments
The 2025-2030 World Outlook for Immunology Treatments This study covers the world outlook for immunology treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Drugs
The 2025-2030 World Outlook for Erythropoietin Drugs This study covers the world outlook for erythropoietin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs This study covers the world outlook for biosimilars and follow-on biologics drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables This study covers the world outlook for generic biosimilar large molecule injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption
The 2025-2030 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption This study covers the world outlook for biobetters - high efficiency and economical costs Foster adoption across more than 190 countries. For each year reported, estimates are given for the latent deman ... Read More
-
The 2025-2030 World Outlook for Erythropoietins
The 2025-2030 World Outlook for Erythropoietins This study covers the world outlook for erythropoietins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents This study covers the world outlook for erythropoietin stimulating agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics This study covers the world outlook for biosimilars and follow-on biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies This study covers the world outlook for biosimilar monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for PEGylated Proteins
The 2025-2030 World Outlook for PEGylated Proteins This study covers the world outlook for PEGylated proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics Drugs
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics Drugs This study covers the world outlook for biosimilars and follow-on biologics drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2023-2028 World Outlook for Erythropoietins
The 2023-2028 World Outlook for Erythropoietins This study covers the world outlook for erythropoietins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2023-2028 World Outlook for Erythropoietin Stimulating Agents
The 2023-2028 World Outlook for Erythropoietin Stimulating Agents This study covers the world outlook for erythropoietin stimulating agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2023-2028 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption
The 2023-2028 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption This study covers the world outlook for biobetters - high efficiency and economical costs Foster adoption across more than 190 countries. For each year reported, estimates are given for the latent deman ... Read More
-
The 2023-2028 World Outlook for Generic Biosimilars
The 2023-2028 World Outlook for Generic Biosimilars This study covers the world outlook for generic biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2023-2028 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars
The 2023-2028 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars This study covers the world outlook for recombinant non-glycosylated protein biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2023-2028 World Outlook for Generic Biosimilar Large Molecule Injectables
The 2023-2028 World Outlook for Generic Biosimilar Large Molecule Injectables This study covers the world outlook for generic biosimilar large molecule injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2023-2028 World Outlook for Biosimilars and Related Biologics
The 2023-2028 World Outlook for Biosimilars and Related Biologics This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2023-2028 World Outlook for Biosimilars
The 2023-2028 World Outlook for Biosimilars This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
Research Assistance
